✦ LIBER ✦

Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma

✍ Scribed by Alberto Pappo; Nancy R. Schneider; Joann M. Sanders; George R. Buchanan

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 306 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910915)68:6<1373::aid-cncr2820680631>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Granulocytic sarcoma of the uterus compl

Granulocytic sarcoma of the uterus complicating myelodysplastic syndrome

✍ Wong, K.F.; Yu, P.H.; Chu, Y.C. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

Immunosuppressive therapy for hypoplasti

Immunosuppressive therapy for hypoplastic myelodysplastic syndrome

✍ Douwe H. Biesma; Jan G. van den Tweel; Leo F. Verdonck 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Background: Hypoplastic myelodysplastic syndrome (mds) is characterized by dysplasia and hypocellularity. the treatment of choice for young patients is bone marrow transplantation. ## Methods: This report describes the effect of immunosuppressive therapy in two patients with hypoplastic mds fo

Update on the therapy for myelodysplasti

Update on the therapy for myelodysplastic syndrome

✍ Margaret T. Kasner; Selina M. Luger 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Nonmyeloablative allogeneic bone marrow

Nonmyeloablative allogeneic bone marrow transplantation for treatment of myelodysplastic syndrome complicated by recent intracerebral hemorrhage

✍ Korenori Ohtsubo; Ken Takase; Koji Nagafuji; Hideho Henzan; Tetsuya Tanimoto; Ta 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Recurrent spleen enlargement during cycl

Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome

✍ Dr. A. Delmer; M. Karmochkine; M. Cadiou; H. Gerhartz; R. Zittoun 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

High incidence of secondary myelodysplas

High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas

✍ C. Corti; C. Theodore; C. Bayle; P. Rougier; F. Nasr; J. M. Cosset; T Girinsky; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

The incidence of secondary myelodysplastic syndromes (MDS) are rarely reported in an homogeneous patient population treated for non-Hodgkin's lymphoma (NHL). Less than 10 per cent of secondary MDS are usually observed in patients treated for Hodgkin's disease and NHL. Data on the incidence of second